Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dermatomyositis and drugs.

A L Dourmishev1, L A Dourmishev

  • 1Department of Dermatology, University of Medicine, Sofia, Bulgaria.

Advances in Experimental Medicine and Biology
|December 22, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paraneoplastic dermatomyositis associated with testicular cancer: a case report and literature review.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica·2010
Same author

Thyroid function and autoimmunity in children and adolescents with vitiligo.

Journal of the European Academy of Dermatology and Venereology : JEADV·2003
Same author

D-penicillamine induced polymyositis and morphea in a woman with Hashimoto thyroiditis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2002
Same author

Inflammatory linear verrucous epidermal nevus.

Cutis·2002
Same author

Dermatomyositis associated with malignancy. 12 case reports.

Advances in experimental medicine and biology·1999
Same author

Waardenburg syndrome.

International journal of dermatology·1999
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Dermatomyositis is an inflammatory condition affecting skin and muscles. Drug-induced dermatomyositis, though rare, offers insights into the disease's underlying pathogenic mechanisms.

Area of Science:

  • Rheumatology
  • Dermatology
  • Neurology

Background:

  • Dermatomyositis (DM) is an idiopathic inflammatory disorder characterized by skin and skeletal muscle involvement.
  • Variations include polymyositis (PM), inclusion body myositis, amyopathic dermatomyositis, juvenile dermatomyositis, and paraneoplastic dermatomyositis in adults.
  • Overlap syndromes (OS) like scleromyositis and anti-synthetase syndrome involve combinations of autoimmune conditions and specific antibodies.

Purpose of the Study:

  • To elucidate the diverse clinical presentations and classifications of dermatomyositis.
  • To highlight the significance of drug-induced dermatomyositis in understanding disease pathogenesis.
  • To differentiate related idiopathic inflammatory myopathies and overlap syndromes.

Main Methods:

Related Experiment Videos

  • Review of existing literature on dermatomyositis and related conditions.
  • Classification based on clinical presentation, muscle biopsy findings, and autoantibody profiles.
  • Analysis of drug-induced cases as models for pathogenic mechanisms.

    • Main Results:

    • Dermatomyositis encompasses a spectrum from skin-only to muscle-involving forms, with distinct subtypes.
    • Juvenile DM differs from adult DM regarding malignancy association.
    • Drug-induced dermatomyositis, though rare, provides valuable clues to disease mechanisms.

    Conclusions:

    • Dermatomyositis presents with varied clinical phenotypes and associations.
    • Understanding drug-induced dermatomyositis is crucial for unraveling the complex pathogenesis of idiopathic inflammatory myopathies.
    • Accurate classification aids in diagnosis and management of these distinct conditions.